ASCO GU 2024: Updates in the Treatment of Advanced Renal Cell Carcinoma - Episode 5
Chandler H. Park, MD, discusses the LEAP study investigating lenvatinib plus pembrolizumab in patients with renal cell carcinoma with brain metastasis.